Influenza Diagnostics Market 2019 Thriving Worldwide 2019-2025: Focusing on Top Leading Players like Novartis AG, Roche Diagnostics, Sekisui Diagnostics

Influenza is a contagious respiratory illness that the influenza virus causes leading to the infection of nose, throat, and sometimes the lungs. It can result into mild to severe illness and sometimes can lead to death. Three types of influenza virus affect people that includes: type A, type B, and type C. Influenza is spread via infectious respiratory secretions that is caused by the formation of aerosol due to direct contact with an infected person.

The global influenza diagnostics market was valued at USD 492.42 million in 2018, and is estimated to be valued at USD 731.97 million in 2025, witnessing a CAGR of +6%.

Get Sample Copy of influenza diagnostics Market at: https://www.omrglobal.com/request-sample/influenza-diagnostics-market

Some of the key players operating in the global influenza diagnostics market are Abbott Laboratories Inc., Novartis AG, Roche Diagnostics, Sekisui Diagnostics, SA Scientific, Inc., and several others.

The influenza can cause seasonal epidemics along with high levels of mortality and morbidity. A number of factors are responsible for the overall growth of the global influenza diagnostics market. Increasing prevalence of influenza and related chronic disease along with the rising geriatric population base is one of the major factors for the growth of the market. However, increasing price of diagnostic kits and reagents hinder the growth of the market.

Moreover, there is a huge opportunity of the global influenza diagnostic market in the near future due to enormous funding and investment, and support provided by the government for influenza diagnostics. For an instance, San Diego-based Cue Health was awarded up to $30 million by the US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority. The funding was provided for enhancing the development and regulatory validation of over-the-counter and professional-use influenza and multiplex respiratory pathogen diagnostic cartridges for health monitoring system of the company.

For More Information get A full report of influenza diagnostics is available at: https://www.omrglobal.com/industry-reports/influenza-diagnostics-market

The influenza diagnostics market can be segmented on the basis of, type, test type and end users. Based on the type, the influenza diagnostics market is bifurcated as type A flu, type B flu and type C flu. On the basis of test type, the market is diversified as rapid influenza diagnostic test, serological assay, nucleic acid sequence-based amplification test, loop-mediated isothermal amplification-based assay, simple amplification-based assay and other tests. Based on the end users, the influenza diagnostics market is sub-divided as hospitals, and research labs.

Global influenza diagnostics Market- Segmentation by Region

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy

Rest of Europe

Asia-Pacific

• China
• Japan
• India

Rest of Asia-Pacific

Rest of the World

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

For More Information, Visit Orion Market Research

This release was published on openPR.